Science Explorer Back to mapMap
Discussion
Researcher · John Paul II Hospital · Poland

Grzegorz Czyżewicz

Grzegorz Czyżewicz publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer Immunotherapy and Biomarkers.

OpenAlex
World rank
#3,973,686
of 7,710,434 ranked researchers
Rank in Poland
#28,925
of 100,960
Works
38
Citations
2.3k
Citations per work
61.8
h-index
12
i10-index 12Top 42% in Pulmonary and Respiratory Medicine
Grzegorz Czyżewicz

What does Grzegorz Czyżewicz research?

Grzegorz Czyżewicz's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (13%).

Health Sciences: 29 works · 76.1% of their workMedicine: 29 works · 76.1% of their workPulmonary and Respiratory Medicine: 15 works · 39.8% of their workOncology: 11 works · 29.2% of their workEpidemiology: 2 works · 4.4% of their workInternal Medicine: 1 works · 2.7% of their workLife Sciences: 5 works · 13.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 13.3% of their workCancer Research: 3 works · 8.0% of their workMolecular Biology: 2 works · 5.3% of their workEverything else: 4 works · 10.6% of their workTHEIR WORKGrzegorzCzyżewicz38works
Life Sciences13%Health Sciences76%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2976.1%
    1. Biochemistry, Genetics and Molecular Biology513.3%
  3. Everything else410.6%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology29% of their works
  3. 3Cancer Research8% of their works
  4. 4Molecular Biology5% of their works
  5. 5Epidemiology4% of their works
  6. 6Internal Medicine3% of their works

Research topics

Which keywords describe Grzegorz Czyżewicz's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy513 topics
  2. Clinical Trials442 topics
  3. ALK Inhibitors291 topic
  4. EGFR Mutations291 topic
  5. Chemotherapy273 topics
  6. Genomic Profiles151 topic
  7. Small-Cell Lung Cancer151 topic
  8. CT Screening91 topic
  9. Immune Checkpoint Blockade91 topic
  10. Lung Cancer91 topic
  11. PD-1 and PD-L191 topic
  12. Cancer Genomics71 topic
  13. Mutational Signatures71 topic
  14. Antithrombotic Therapy31 topic
  15. Cetuximab31 topic
  16. KRAS Mutations31 topic
  17. Multiple Primary Cancers31 topic
  18. Second Primary Neoplasms31 topic
  19. Venous Thromboembolism31 topic

Where does Grzegorz Czyżewicz work?

Grzegorz Czyżewicz's main affiliation in the publication record is John Paul II Hospital, Poland.

How many publications and citations does Grzegorz Czyżewicz have?

OpenAlex counts 38 works and 2,348 citations for Grzegorz Czyżewicz, an h-index of 12, ranking #3,973,686 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Grzegorz Czyżewicz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.